Consistent with transcriptional changes, histological analysis also revealed that infiltration of CD11b+ myeloid cells and F4/80+CD11b+ tumor-associated macrophages was significantly suppressed in STING-treated mice compared with control mice (figure 4E). The gene discussed is STING1; the disease is neoplasm.